FactPipe
5
Your Rating:
x
Medical
Inhibikase stock sinks on FDA clinical hold of Parkinson's drug
Your Rating:
Inhibikase Therapeutics has been left stumped and its stock sunk after the FDA unexpectedly placed a clinical hold on its mid-stage Parkinson’s drug.
